Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-19-002304
Filing Date
2019-07-23
Accepted
2019-07-23 18:50:49
Documents
2
Period of Report
2019-07-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3737
2 POWER OF ATTORNEY genkin_poa.htm EX-24.1 6698
  Complete submission text file 0001683168-19-002304.txt   11940
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Issuer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address
Genkin Dmitry (Reporting) CIK: 0001711592 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37937 | Film No.: 19968970